Dna Group (T.R.) Full Year 2024 Earnings: EPS: ₪0.18 (vs ₪0.01 loss in FY 2023)

Simply Wall St

March 17, 2025

Dna Group (T.R.) (TLV:DNA) Full Year 2024 Results

Key Financial Results

Net income: ₪23.4m (up from ₪1.18m loss in FY 2023).
EPS: ₪0.18 (up from ₪0.01 loss in FY 2023).

earnings-and-revenue-history — TASE:DNA Earnings and Revenue History March 17th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Dna Group (T.R.) shares are down 4.9% from a week ago.

Risk Analysis

You should learn about the 4 warning signs we've spotted with Dna Group (T.R.) (including 3 which are concerning).

Mobile Infrastructure for Defense and Disaster

The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.

Get the investor briefing before the next round of contracts

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.